A Retrospective Analysis of Cervical Cytology Using Pap Smear among Symptomatic Women Attending Gynaecology OPD in a Secondary Care Hospital in Northern India

  • Ravneet Kaur Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Shashi Kant Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Shalli Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Jammu, India.
  • Rama Shankar Rath Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Gorakhpur, India.
Keywords: Cervical Cancer, Pap Smear, Cytology, Rural, Symptomatic, Screening


Background: Cervical cancer is the second leading cause of cancer deaths among women in India. It develops well-defined premalignant lesions before the development of invasive lesions, and hence, early diagnosis and treatment may prevent progression to advanced stages. Papanicolaou (Pap) smear examination is a useful screening tool for cervical cancer. However, it is resource-intensive and requires skilled manpower. In routine outpatient settings in tertiary care facilities, Pap smear examination is conducted among symptomatic women. Analysis of such data may provide useful information regarding premalignant lesions, but there is a paucity of data from secondary care health facilities, which cater to rural women who are at a higher risk of carcinoma cervix. Objective: To study the pattern of Pap smear abnormalities and identification of high-risk lesions among symptomatic women attending a secondary care hospital in a rural area.
Methods: We performed a retrospective analysis of records of Pap smear results from January 2013 to May 2018, from a secondary care hospital in northern India. The data were analysed and age-wise cytological patterns were reported as percentages.
Results: A total of 393 Pap smear examinations were performed during the study period. Results were available for 355 smears. The commonest abnormality was inflammation (83.6%). The prevalence of cervical epithelial abnormalities was 4.2%, including atypical squamous cell of undetermined significance (ASCUS) (0.8%), high-grade squamous intraepithelial lesion (HSIL) (0.3%), and squamous cell metaplasia (2.9 %).
Conclusion: Abnormal cytology is common among symptomatic women. Linkages between district hospitals and medical colleges may improve screening

How to cite this article:
Kaur R, Kant S, Shalli, Rath RS. A Retrospective
Analysis of Cervical Cytology Using Pap Smear
among Symptomatic Women Attending
Gynaecology OPD in a Secondary Care Hospital
in Northern India. Epidem Int. 2023;8(2):7-11.

DOI: https://doi.org/10.24321/2455.7048.202308


S ng H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020:

GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. [PubMed] [Google Scholar]

World Health Organization: International Agency for Research on Cancer [Internet]. GLOBOCAN 2020; [cited

May 17]. Available from: https://gco.iarc.fr/today/ data/factsheets/populations/356-india-fact-sheets.pdf

World Health Organization [Internet]. Cervical cancer country profiles; 2021 [cited 2023 May 14]. Available

from: https://www.who.int/teams/noncommunicablediseases/surveillance/data/cervical-cancer-profiles

Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, Burger EA, Martin D, Nguyen DT, Benard E, Sy S,

Regan C, Drolet M, Gingras G, Laprise JF, Torode J, Smith MA, Fidarova E, Trapani D, Bray F, Ilbawi A, Broutet N, Hutubessy R. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middleincome countries. Lancet. 2020;395(10224):591-603. [PubMed] [Google Scholar].

Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average

levels and large inequalities. PLoS Med. 2008 Jun 17;5(6):e132. [PubMed] [Google Scholar]

Köse FM, Naki MM. Cervical premalignant lesions and their management. J Turk Ger Gynecol Assoc. 2014;15(2):109-21. [PubMed] [Google Scholar]

World Health Organization [Internet]. WHO guideline for screening and treatment of cervical pre-cancer

lesions for cervical cancer prevention. 2nd ed. Geneva: World Health Organization; 2021 [cited 2023 Aug 31].

Available from: https://www.who.int/publicationsdetail-redirect/9789240030824 [PubMed] [Google Scholar]

Ministry of Health and Family Welfare, Government of India [Internet]. National programme for prevention

and control of cancer, diabetes, cardiovascular diseases & stroke: Operational guidelines (Revised: 2013-17);

[cited 2023 Aug 31]. Available from: https:// main.mohfw.gov.in/sites/default/files/Operational%20 Guidelines%20of%20NPCDCS%20%28Revised%20 -%202

Jain A, Ganesh B, Bobdey SC, Sathwara JA, Saoba S. Sociodemographic and clinical profile of cervical cancer patients visiting in a tertiary care hospital in India. Indian J Med Paediatr Oncol. 2017;38(3):291-5. [PubMed] [Google Scholar]

Bamanikar SA, Baravkar D, Chandanwale S, Dharwadkar A, Paranjape S. Study of cervical cytology and its

correlation with clinical and histopathological findings. Clin Cancer Investig J. 2016;5(5):403-8. [Google Scholar]

Kerkar RA, Kulkarni YV. Screening for cervical cancer: an overview. J Obstet Gynecol India. 2006;56(2):115- 22. [Google Scholar]

All India Institute of Medical Sciences, New Delhi [Internet]. 66th AIIMS Annual Report 2021-2022; [cited 2023 Aug 31]. Available from: https://www.aiims.edu/ images/pdf/annual_reports/english.pdf

Valdespino VM, Valdespino VE. Cervical cancer screening: state of the art. Curr Opin Obstet Gynecol. 2006 Feb;18(1):35-40. [PubMed] [Google Scholar]

Solomon D. The Bethesda System for reporting cervical/ vaginal cytologic diagnosis: an overview. Int J Gynecol Pathol. 1991;10(4):323-5. [PubMed] [Google Scholar]

Tailor HJ, Patel RD, Patel RD, Patel PR, Bhagat VM. Study of cervical pap smears in a tertiary care hospital

of south Gujarat, India. Int J Res Med Sci. 2016;4(1):286- 8. [Google Scholar]

Vedavathi V, Anusuya SK, Parimala BS, Rohini NS. Analysis of cervical cytology using PAP smear in women

residing in Bangalore Rural, India. J Evid Based Med Health. 2019;6(51):3156-9.

Likhar KS, Saluja A, Gupta SG, Hazari RA, Likhar SK. Precancerous and cancerous lesions of cervix diagnosed

by Pap’s smear - a hospital based study. J Evol Med Dent Sci. 2014;3(8):1899-904. [Google Scholar]

Kaveri SB, Khandelwal S. Role of Pap smear N cervical biopsy in unhealthy cervix. J Sci Innov Res. 2015;4(1):4-

[Google Scholar]

Verma A, Verma S, Vashist S, Attri S, Singhal A. A study on cervical cancer screening in symptomatic women

using Pap smear in a tertiary care hospital in rural area of Himachal Pradesh, India. Middle East Fertil Soc J.

;22(1):39-42. [Google Scholar]

Garg P, Mishra S, Divedi P. Cervical Pap smear study and its utility in cancer screening in patients attending

out-patient department in a tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2021;10(9):352-4.

Sachan PL, Singh M, Patel ML, Sachan R. A study on cervical cancer screening using pap smear test and

clinical correlation. Asia Pac J Oncol Nurs. 2018;5(3):337- 41. [PubMed] [Google Scholar]

Gupta N, Bhar VS, Rajwanshi A, Suri V. Unsatisfactory rate in liquid-based cervical samples as compared

to conventional smears: a study from tertiary care hospital. Cytojournal. 2016;13:14. [PubMed] [Google Scholar]

Ranabhat SK, Shrestha R, Tiwari M. Analysis of abnormal epithelial lesions in cervical Pap smears in Mid-Western Nepal. J Pathol Nepal. 2011;1(1):30-3.

Tejeswini V, Premalatha P. Pap smear examination-its utility in various cervical lesions. Indian J Pathol Oncol.

Apr;3(2):242-6. [Google Scholar]

Mulay K, Swain M, Patra S, Gowrishankar S. A comparative study of cervical smears in an urban hospital in India and a population-based screening program in Mauritius. Indian J Pathol Microbiol. 2009;52(1):34-7. [PubMed] [Google Scholar]